La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Animals »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Animal origin < Animals < Animals, Genetically Modified  Facettes :

List of bibliographic references indexed by Animals

Number of relevant bibliographic references: 546.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000021 (2017) Véronique Paban [France] ; Béatrice Loriod [France] ; Claude Villard [France] ; Luc Buee [France] ; David Blum [France] ; Susanna Pietropaolo [France] ; Yoon H. Cho [France] ; Sylvie Gory-Faure [France] ; Elodie Mansour [France] ; Ali Gharbi [France] ; Béatrice Alescio-Lautier [France]Omics analysis of mouse brain models of human diseases.
000025 (2017) Wissem Deraredj Nadim ; Viorel Simion ; Helene Benedetti ; Chantal Pichon ; Patrick Baril ; Severine Morisset-Lopez [France]MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
000114 (2016) Samuela Cataldi [Italie] ; Michela Codini [Italie] ; Stéphane Hunot [France] ; François-Pierre Légeron [France] ; Ivana Ferri [Italie] ; Paola Siccu [Italie] ; Angelo Sidoni [Italie] ; Francesco Saverio Ambesi-Impiombato [Italie] ; Tommaso Beccari [Italie] ; Francesco Curcio [Italie] ; Elisabetta Albi [Italie]e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
000121 (2016) R. Magnard [France] ; Y. Vachez [France] ; C. Carcenac [France] ; P. Krack [France] ; O. David [France] ; M. Savasta [France] ; S. Boulet [France] ; S. Carnicella [France]What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
000127 (2016) Sandra Dovero [France] ; Christian Gross [France] ; Erwan Bezard [France]Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?
000137 (2016) Santiago Perez-Lloret [Argentine] ; Olivier Rascol [France]The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.
000151 (2016) Lawrence Fourgeaud [États-Unis] ; Paqui G. Través [États-Unis] ; Yusuf Tufail [États-Unis] ; Humberto Leal-Bailey [États-Unis] ; Erin D. Lew [États-Unis] ; Patrick G. Burrola [États-Unis] ; Perri Callaway [États-Unis] ; Anna Zag Rska [États-Unis] ; Carla V. Rothlin [États-Unis] ; Axel Nimmerjahn [États-Unis] ; Greg Lemke [États-Unis]TAM receptors regulate multiple features of microglial physiology.
000159 (2016) Matthieu F. Bastide [France] ; Simone Bido [France] ; Nathalie Duteil [France] ; Erwan Bézard [France]Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia.
000164 (2016) Loubna Boukhzar ; Abdallah Hamieh ; Dorthe Cartier ; Yannick Tanguy ; Ifat Alsharif ; Matthieu Castex ; Arnaud Arabo ; Sana El Hajji ; Jean-Jacques Bonnet ; Mohammed Errami ; Anthony Falluel-Morel ; Abdeslam Chagraoui ; Isabelle Lihrmann ; Youssef AnouarSelenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
000165 (2016) Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France]Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
000168 (2016) Manale Bensaid [France] ; Patrick P. Michel [France] ; Stewart D. Clark [États-Unis] ; Etienne C. Hirsch [France] ; Chantal François [France]Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
000199 (2016) Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000215 (2016) Wisam Dieb [France] ; Omar Ouachikh [France] ; Sofia Alves [France] ; Yves Boucher [France] ; Franck Durif [France] ; Aziz Hafidi [France]Nigrostriatal dopaminergic depletion increases static orofacial allodynia
000221 (2016) Mohammed Filali [Canada] ; Robert Lalonde [France]Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.
000222 (2016) Fannie Darlot [France] ; Cécile Moro [France] ; Nabil El Massri [Australie] ; Claude Chabrol [France] ; Daniel M. Johnstone [Australie] ; Florian Reinhart [France] ; Diane Agay [France] ; Napoleon Torres [France] ; Dhaïf Bekha [France] ; Vincent Auboiroux [France] ; Thomas Costecalde [France] ; Cassandra L. Peoples [Australie] ; Helena D T. Anastascio [Australie] ; Victoria E. Shaw [Australie] ; Jonathan Stone [Australie] ; John Mitrofanis [Australie] ; Alim-Louis Benabid [France]Near-infrared light is neuroprotective in a monkey model of Parkinson disease.
000223 (2016) Mathieu Bourdenx [France] ; Jonathan Daniel [France] ; Emilie Genin [France] ; Federico N. Soria [France] ; Mireille Blanchard-Desce [France] ; Erwan Bezard [France] ; Benjamin Dehay [France]Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases
000232 (2016) Aderbal Silva Aguiar [Brésil] ; Marcelo Duzzioni [Brésil] ; Aline Pertile Remor [Brésil] ; Fabrine Sales Massafera Tristão [France] ; Filipe C. Matheus [Brésil] ; Rita Raisman-Vozari [France] ; Alexandra Latini [Brésil] ; Rui Daniel Prediger [Brésil]Moderate-Intensity Physical Exercise Protects Against Experimental 6-Hydroxydopamine-Induced Hemiparkinsonism Through Nrf2-Antioxidant Response Element Pathway.
000236 (2016) Carine Chassain [France] ; Christophe Melon [France] ; Pascal Salin [France] ; Flora Vitale [France] ; Sébastien Couraud [France] ; Franck Durif [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France]Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
000240 (2016) Lucie Hopes [France] ; Guillaume Grolez [France] ; Caroline Moreau [France] ; Renaud Lopes [France] ; Gilles Ryckewaert [France] ; Nicolas Carrière [France] ; Florent Auger [France] ; Charlotte Laloux [France] ; Maud Petrault [France] ; Jean-Christophe Devedjian [France] ; Regis Bordet [France] ; Luc Defebvre [France] ; Patrice Jissendi [France] ; Christine Delmaire [France] ; David Devos [France]Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
000243 (2016) Suzanne Lesage [France] ; Valérie Drouet [France] ; Elisa Majounie [États-Unis] ; Vincent Deramecourt [France] ; Maxime Jacoupy [France] ; Aude Nicolas [France] ; Florence Cormier-Dequaire [France] ; Sidi Mohamed Hassoun [France] ; Claire Pujol [France] ; Sorana Ciura [France] ; Zoi Erpapazoglou [France] ; Tatiana Usenko [France] ; Claude-Alain Maurage [France] ; Mourad Sahbatou [France] ; Stefan Liebau [Allemagne] ; Jinhui Ding [États-Unis] ; Basar Bilgic [Turquie] ; Murat Emre [Turquie] ; Nihan Erginel-Unaltuna [Turquie] ; Gamze Guven [Turquie] ; François Tison [France] ; Christine Tranchant [France] ; Marie Vidailhet [France] ; Jean-Christophe Corvol [France] ; Paul Krack [France] ; Anne-Louise Leutenegger [France] ; Michael A. Nalls [États-Unis] ; Dena G. Hernandez [États-Unis] ; Peter Heutink [Allemagne] ; J. Raphael Gibbs [États-Unis] ; John Hardy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Thomas Gasser [Allemagne] ; Alexandra Durr [France] ; Jean-François Deleuze [France] ; Meriem Tazir [Algérie] ; Alain Destée [France] ; Ebba Lohmann [Turquie, Allemagne] ; Edor Kabashi [France] ; Andrew Singleton [États-Unis] ; Olga Corti [France] ; Alexis Brice [France]Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
000248 (2016) Jean-Marc Taymans [France] ; Elisa Greggio [Italie]LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Animals" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Animals" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Animals
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024